Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94107, USA.
Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
Genes (Basel). 2023 Sep 23;14(10):1851. doi: 10.3390/genes14101851.
:: gene fusion is a rare recurrent genomic rearrangement associated with hematologic malignancies, and frequently occurs with additional anomalies. Due to the opposite chromosome orientations of the and genes, an oncogenic in-frame :: gene fusion cannot be formed by a simple translocation. The molecular mechanism of the :: fusion and the significance of co-occurring anomalies are not fully understood. We characterized genomic alterations in an individual with :: gene-fusion-positive myeloid neoplasm using various genomic technologies. Our findings uncovered a molecular mechanism of the :: fusion, in which a paracentric inversion within the short arm of chromosome 12 (12p) and a translocation between the long arm of a chromosome 9 and the 12p with the inversion were involved. In addition, we detected multiple additional anomalies in the individual, and our findings suggested that the :: fusion occurred as a secondary event in a subset of cells with the additional anomalies. We speculate that the additional anomalies may predispose to further pathogenic changes, including :: fusion, leading to neoplastic transformation.
:: 基因融合是一种与血液系统恶性肿瘤相关的罕见、反复出现的基因组重排,常伴有其他异常。由于 和 基因的染色体方向相反,因此简单的易位不能形成致癌的:: 基因融合。:: 融合的分子机制以及伴发异常的意义尚不完全清楚。我们使用各种基因组技术对一个:: 基因融合阳性的髓系肿瘤个体的基因组改变进行了特征描述。我们的研究结果揭示了:: 融合的分子机制,涉及 12 号染色体(12p)短臂内的旁中心倒位以及 9 号染色体长臂与带有倒位的 12p 之间的易位。此外,我们还在个体中检测到多个额外的异常,我们的研究结果表明,在伴有额外异常的部分细胞中,:: 融合是一个继发事件。我们推测这些额外的异常可能导致进一步的致病变化,包括:: 融合,从而导致肿瘤转化。